19. The Prevention and Management of Pain in Dogs

  1. M. Christine Zink DVM, PhD, Dipl ACVP and
  2. Janet B. Van Dyke DVM
  1. Mark E. Epstein DVM, Dipl ABVP (C/F), CVPP

Published Online: 28 JUN 2013

DOI: 10.1002/9781118783443.ch19

Canine Sports Medicine and Rehabilitation

Canine Sports Medicine and Rehabilitation

How to Cite

Zink, M. C. and Van Dyke, J. B. (2013) The Prevention and Management of Pain in Dogs, in Canine Sports Medicine and Rehabilitation, John Wiley & Sons, Inc., West Sussex, UK. doi: 10.1002/9781118783443.ch19

Publication History

  1. Published Online: 28 JUN 2013
  2. Published Print: 11 APR 2013

ISBN Information

Print ISBN: 9780813812168

Online ISBN: 9781118783443



  • acute pain management;
  • alpha-2 agonist;
  • chronic pain management;
  • dogs;
  • intravenous lidocaine;
  • multimodal approach;
  • nonsteroidal anti-inflammatory drugs (NSAIDs);
  • opioids;
  • pain-modifying analgesic drugs (PMADs);
  • subanesthetic ketamine


This chapter is a succinct overview of the multimodal approach to the prevention and treatment of acute and chronic pain in dogs, utilizing evidence-based veterinary medicine (EBVM) insofar as possible, and a consensus of expert opinion otherwise. Drug classes and modalities discussed include nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, alpha-2 agonists, locoregional anesthesia, subanesthetic ketamine, and a variety of other pain-modifying analgesic drugs (PMADs) in common use (e.g., tramadol, gabapentin, amantadine, and others). The discussion also includes tips for practical clinical use, with an emphasis on safe and responsible use of the various drug classes. In addition, descriptions of other drugs possibly on the horizon for veterinary use (based on use in human medicine) are included. Lastly, evidence-based approaches to managing postsurgical and different varieties of chronic pain (osteoarthritis, osteosarcoma, and noninflammatory) are described, with sample cases to illustrate.